After the implementation of standard first line chemotherapy with platinum and antifolates in pleural mesothelioma, patients are confronted with a need for second line treatment at relapse or progression. We conducted a systematic review of the literature for the activity, effectiveness and toxicity of second line treatment. The results are presented according to the class of drugs: chemotherapy and targeted or biological agent.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lungcan.2015.06.018 | DOI Listing |
Publication Analysis
Top Keywords
pleural mesothelioma
8
systematic review
8
second treatment
8
second therapy
4
therapy malignant
4
malignant pleural
4
mesothelioma systematic
4
review implementation
4
implementation standard
4
standard chemotherapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!